First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Title:
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Author:
Baas, Paul Scherpereel, Arnaud Nowak, Anna K Fujimoto, Nobukazu Peters, Solange Tsao, Anne S Mansfield, Aaron S Popat, Sanjay Jahan, Thierry Antonia, Scott Oulkhouir, Youssef Bautista, Yolanda Cornelissen, Robin Greillier, Laurent Grossi, Francesco Kowalski, Dariusz Rodríguez-Cid, Jerónimo Aanur, Praveen Oukessou, Abderrahim Baudelet, Christine Zalcman, Gérard